Betul Hatipoglu, director of the Center for Diabetes, Obesity and Metabolism at Case Western Reserve University and of the Diabetes and Obesity Center at University Hospitals Cleveland Medical Center, says microdosing Ozempic, Zepbound or another GLP-1 drug might mean: Taking a lower dose than what was prescribed or studied in clinical trials Taking a half-dose every few days instead of a full dose once weekly Taking a full dose less often, such as every 10 or 14 days instead of every seven While these approaches are often grouped together online under the umbrella of "microdosing," they're not exactly the same thing
As your go-to resource for cardiometabolic risk reduction, follow CMHC for the latest news, research, and innovations to advance your career and practice!
Mechanisms of Glycemic Control (The Pancreas) The primary mechanism for glycemic control involves the activation of GLP-1 receptors (GLP-1R) on pancreatic islet cells, initiating intracellular signaling cascades such as the cAMP/PKA and PI3K/Akt pathways (Figure 1)(Zheng et al., 2024)
JMIR Ment
Many peptides discussed online are not FDA-approved for general clinical use